Ricerca in clinica e in laboratorio

, Volume 15, Issue 2, pp 177–183 | Cite as

Cytolytic activity of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Analysis at the population and clonal level

  • Roberto Biassoni
  • Ignazia Prigione
  • Eddi Di Marco
  • Silvano Ferrini
Original Contributions


T lymphocytes were isolated from ascitic fluid of three patients with ovarian carcinoma at III–IV stage. Surface markers analysis of such purified T cells revealed that T8+ cells were well represented among ascitic T lymphocytes (from 35 to 56%). Low percentages of activated T cells, as indicated by HLA-DR and TAC (interleukin-2 receptor) positivity, were also present. However, fresh ascitic T lymphocytes failed to lyse autologous tumor target cells in a 4-h51Cr release assay. Furthermore, by applying a limiting dilution microculture system that allows optimal conditions for cloning of human T lymphocytes, we derived clones from these populations. From 41 to 63% of clones so obtained had cytolytic activity in a lectin-dependent assay allowing detection of cytolytic T cells of any specificity. More importantly, in all three patients several clones were found to lyse autologous tumor target cells as well. Some of these clones have been studied in more detail: 9 out of 10 expressed the T8+/T4 phenotype, whereas only one was T8/T4+; 6 out of 9 clones had a definite NK-like activity, while none of them lysed autologous PHA-lymphoblasts.


Cytolytic T lymphocytes Lectin-dependent killing Natural killer activity Ovarian cancer T cell clones 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allavena P., Introna M., Sessa C., Mangioni C., Mantovani A.: Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells — J. nat. Cancer Inst.68, 555, 1982.PubMedGoogle Scholar
  2. 2.
    Badger A. M., Oh S. K., Moolten F. R.: Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity — Cancer Res.41, 1133, 1981.PubMedGoogle Scholar
  3. 3.
    Delglish L., Jacobs A. J., Cohen C. J.: Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response — Amer. J. Obstetr. Gynecol.144, 885, 1982.Google Scholar
  4. 4.
    Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A.: The lymphokine-activated killer cell phenomenon: lysis of NK-resistant fresh solid tumor cells by IL-2 activated autologous human peripheral blood lymphocytes — J. exp. Med.155, 1823, 1982.PubMedCrossRefGoogle Scholar
  5. 5.
    Grimm E. A., Ramsey K. M., Mazumder A., Wilson D. J., Rosenberg S. A.: Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral blood T lymphocytes, memory cytotoxic thymus-derived lymphocytes and natural killer cells — J. exp. Med.157, 884, 1983.PubMedCrossRefGoogle Scholar
  6. 6.
    Haskill S., Becker S., Fowler W.: Mononuclear cell infiltration in ovarian cancer. I. Inflammatory cell infiltrates from tumour and ascites material — Brit. J. Cancer45, 728, 1982.PubMedGoogle Scholar
  7. 7.
    Malissen B., Rebai N., Liabeuf A., Mawas C.: Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal level of the cytolysis inhibiting effect of 7 monoclonal antibodies — Europ. J. Immunol.12, 737, 1982.CrossRefGoogle Scholar
  8. 8.
    Mantovani A., Allavena P., Sessa C., Bolis G., Mangioni C.: Natural killer activity of lymphoid cells isolated from ascitic ovarian tumors — Int. J. Cancer25, 573, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Moretta A., Mingari M. C., Haynes R. P., Sekaly R. P., Moretta L., Fauci A. S.: Phenotypic characterization of human cytolytic T lymphocytes generated in mixed lymphocyte culture — J. exp. Med.153, 213, 1981a.PubMedCrossRefGoogle Scholar
  10. 10.
    Moretta A., Pantaleo G., Moretta L., Mingari M. C., Cerottini J. C.: Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations — J. exp. Med.158, 571, 1983a.PubMedCrossRefGoogle Scholar
  11. 11.
    Moretta A., Pantaleo G., Moretta L., Cerottini J. C., Mingari M. C.: Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity — J. exp. Med.157, 743, 1983b.PubMedCrossRefGoogle Scholar
  12. 12.
    Moretta A., Pantaleo G.: Surface structures involved in human cytolytic T lymphocyte function. In:Feldman N. (Ed.): Human T cell clones: a new approach to immunoregulation. Humana Press, London, 1985. (in press).Google Scholar
  13. 13.
    Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D.: Functional analysis of two human T-Cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG — J. exp. Med.146, 184, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Vose B. M.: Quantitation of proliferative and cytotoxic precursor cells directed against human tumors: limiting dilution analysis in peripheral blood and at the tumor site — Int. J. Cancer30, 135, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Roberto Biassoni
    • 1
  • Ignazia Prigione
    • 1
  • Eddi Di Marco
    • 1
  • Silvano Ferrini
    • 1
  1. 1.Laboratorio di FarmacologiaIstituto Nazionale per la Ricerca sul CancroGenovaItalia

Personalised recommendations